Neoadjuvant therapy of camrelizumab combined with chemotherapy in patients (pts) with resectable esophageal squamous cell cancer (ESCC): Preliminary results of a preoperative phase exploratory clinical trial

被引：0
|
作者：
Dong, Y. [1 ,2 ]
Luo, J. [3 ]
Liu, S. [4 ]
Lin, Y. [5 ]
Han, H. [5 ]
机构：
[1] Shandong First Med Univ, Shandong Canc Hosp & Inst, Thorac Surg, Jinan, Peoples R China
[2] Shandong Acad Med Sci, Jinan, Peoples R China
[3] Shandong Canc Hosp, Oncol, Jinan, Peoples R China
[4] Shandong Univ, Thorac Surg, Shandong Canc Hosp, Jinan, Peoples R China
[5] Jiangsu Hengrui Pharmaceut Co Ltd, Dept Med, Jinan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1225P
引用
收藏
页码：S1109 / S1109
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant therapy of camrelizumab combined with chemotherapy in patients (pts) with resectable esophageal squamous cell cancer (ESCC)
    Dong, Y.
    Luo, J.
    Liu, S.
    Han, H.
    Lin, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S866 - S866
  • [2] Neoadjuvant therapy of camrelizumab combined with chemotherapy in patients (pts) with resectable esophageal squamous cell cancer (ESCC): A single-center, single-arm, exploratory clinical trial
    Yang, Ji Chen
    Jiao, Wenjie
    Hua, Feng
    Zhao, Xiaoming
    Yang, Wenfeng
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Neoadjuvant sintilimab combined with chemotherapy in patients with resectable esophageal squamous cell carcinoma (ESCC): Preliminary results from a phase II study.
    Guo, Jincheng
    Qiao, Chengrui
    Lu, Jiabin
    Yang, Shiqing
    Zhang, Boyi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16008 - E16008
  • [4] Three courses of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma (ESCC): A prospective phase II clinical trial
    Yang, G.
    Sun, X.
    Yang, H.
    Luo, G.
    Zheng, Y.
    Huang, M.
    Wang, Z.
    Cai, P.
    He, H.
    Xiang, J.
    Cai, M.
    Fu, J.
    Liu, Q.
    Yi, H.
    Zhong, J.
    Huang, Y.
    Guo, Q.
    Zhang, X.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1122 - S1122
  • [5] Efficacy and safety of camrelizumab combined with chemotherapy versus chemotherapy alone as preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma: Preliminary results from a multicenter, prospective, randomized controlled study
    Zhang, Renquan
    Song, De Sheng
    Liu, Wei
    Yao, Long
    Chen, An Guo
    Ge, Wei
    Hu, Shao Hui
    Chen, Jian
    Huang, Yun Long
    Xun, Jun Rui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (ESCC): A single-arm, phase II trial
    Gong, Lei
    Yang, Yueyang
    Zhang, Hongdian
    Qiao, Yufeng
    Wang, Haitong
    Ren, Peng
    Tang, Peng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Camrelizumab combined with albumin paclitaxel and cisplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESCC).
    Lv, Huilai
    Tian, Yang
    Huang, Chao
    Li, Zhenhua
    Tian, Ziqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): A multicenter, phase 2 study
    Liu, Jun
    Li, Jingpei
    Lin, Wanli
    Shao, Di
    Depypere, Lieven
    Zhang, Zhifeng
    Li, Zhuoyi
    Cui, Fei
    Du, Zesen
    Zeng, Yuan
    Jiang, Shunjun
    He, Ping
    Gu, Xia
    Chen, Huai
    Zhang, Hai
    Lin, Xiaowei
    Huang, Haoda
    Lv, Wenqiang
    Cai, Weiming
    Liang, Wenhua
    Liang, Hengrui
    Jiang, Wenxi
    Wang, Wei
    Xu, Ke
    Cai, Weipeng
    Wu, Kui
    Lerut, Toni
    Fu, Junhui
    He, Jianxing
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (01) : 128 - 137
  • [9] Preoperative pembrolizumab plus chemotherapy for resectable esophageal squamous cell carcinoma (ESCC): The phase II Keystone-001 trial
    Jiang, H.
    Shang, X.
    Xie, Y.
    Zhao, G.
    Zhang, C.
    Zhang, W.
    Liu, L.
    Li, R.
    Yue, J.
    Chen, C.
    Duan, X.
    Ma, Z.
    Sun, Y.
    Yu, J.
    Ren, X.
    ANNALS OF ONCOLOGY, 2023, 34 : S872 - S873
  • [10] Camrelizumab plus chemotherapy as neoadjuvant treatment for resectable locally advanced esophageal squamous cell carcinoma (LA-ESCC): A single-center, randomized, phase II trial
    Lu, Zhihao
    Cao, Yanshuo
    Dai, Liang
    Dong, Fengxiao
    Shen, Lin
    CANCER RESEARCH, 2024, 84 (07)
12345